Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmy Graber

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Drugs in Dermatology : JDD|December 2, 2025
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by AgeLeon H Kircik, Julie C Harper, Hilary Baldwin, et al.
The American Journal of Dermatopathology|November 19, 2011
Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic findingReza S Jacob, Claudine Yap Silva, Jennifer G Powers, et al.
Dermatologic Therapy|December 19, 2021
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacyAyman Grada, James Q Del Rosso, Emmy Graber, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and AdolescentsLawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, et al.
The Journal of Clinical and Aesthetic Dermatology|September 18, 2023
Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of AcneJerry Tan, Zoe D Draelos, Melinda J Gooderham, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES StudyHilary E Baldwin, Emmy Graber, Julie C Harper, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
INDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES StudyEmmy Graber, Hilary E Baldwin, Richard G Fried, et al.
JAMA Dermatology|April 24, 2024
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus StatementMcKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Drugs in Dermatology : JDD|December 2, 2025
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by AgeLeon H Kircik, Julie C Harper, Hilary Baldwin, et al.
The American Journal of Dermatopathology|November 19, 2011
Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic findingReza S Jacob, Claudine Yap Silva, Jennifer G Powers, et al.
Dermatologic Therapy|December 19, 2021
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacyAyman Grada, James Q Del Rosso, Emmy Graber, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and AdolescentsLawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, et al.
The Journal of Clinical and Aesthetic Dermatology|September 18, 2023
Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of AcneJerry Tan, Zoe D Draelos, Melinda J Gooderham, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES StudyHilary E Baldwin, Emmy Graber, Julie C Harper, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
INDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES StudyEmmy Graber, Hilary E Baldwin, Richard G Fried, et al.
JAMA Dermatology|April 24, 2024
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus StatementMcKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Pageof 2